IGF1R and neoplasm: Furthermore suppression of vasculogenesis has also been demonstrated in vitro and in vivo xenograft models [77]. In vivo, tumor formation and growth of RMS cells was inhibited by treating mice with an antibody antagonistic against IGF1R [53, 78, 79] or with TKIs [75, 76, 80].